Detection of Epstein-Barr virus in invasive breast cancers

Journal of the National Cancer Institute

Volumn 91, Issue 16, 1999, Pages 1376-1381

  Bonnet, Mathilde ^a,b   Guinebretiere, Jean Marc ^e   Kremmer, Elisabeth ^c   Grunewald, Virginie ^e   Benhamou, Ellen ^e   Contesso, Genevieve ^e   Joab, Irene ^d  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Klin Grohadern Inst Immunol U   (Germany)

^d UF de Génétique Moléculaire HÔpital Lariboisière   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; PROTEIN EBNA 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN BLOTTING; VIRUS DETECTION;

EID: 0033581152     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.16.1376     Document Type: Article

References (33)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, editors. Virology. Philadelphia (PA): Lippincott-Raven; 1996. p. 2397-446.
2. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A 1994; 91:9131-5.
3. McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995;332:12-8.
4. Wong MP, Chung LP, Yuen ST, Leung SY, Chan SY, Wang E, et al. In situ detection of Epstein-Barr virus in non-small cell lung carcinomas. J Pathol 1995;177:233-40.
5. Raab-Traub N, Rajadurai P, Flynn K, Lanier AP. Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol 1991;65:7032-6.
6. Dimery IW, Lee JS, Blick M, Pearson G, Spitzer G, Hong WK. Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer 1988;61:2475-80.
7. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 1995;55:39-45.
8. Luqmani YA, Shousha S. Presence of Epstein-Barr virus in breast carcinoma. Int J Oncol 1995;6:899-903.
9. Richardson A. Is breast cancer caused by late exposure to a common virus? Med Hypotheses 1997;48:491-7.
10. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538-49.
11. Abhyankar SH, Chiang KY, McGuirk JP, Pati AR, Godder KT, Welsh JA, et al. Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses. Bone Marrow Transplant 1998;21:295-7.
12. Koulibaly M, Diallo SB, Wann AR, Diallo MB, Charlotte F, Le Charpentier Y. Apparently isolated case of African Burkitt lymphoma of the breast localized in the breast [letter]. Ann Pathol 1998;18:237-8.
13. Junker AK, Thomas EE, Radcliffe A, Forsyth RB, Davidson AG, Rymo L. Epstein-Barr virus shedding in breast milk. Am J Med Sci 1991;302:220-3.
14. Kusuhara K, Takabayashi A, Ueda K, Hidaka Y, Minimishima I, Take H, et al. Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic type I in Japan. Microbiol Immunol 1997;41:309-12.
15. Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL. Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer 1998;75:555-8.
16. Chu JS, Chen CC, Chang KJ. In situ detection of Epstein-Barr virus in breast cancer. Cancer Lett 1998;124:53-7.
17. Straus SE, Cohen JI, Tosato G, Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 1993;118:45-58.
18. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991;337:320-2.
19. Montpellier C, Crepieux P, Quatannens B, Delobel B, Croquette MF, Stehelin D, et al. Homologous T and B cells immortalized in vitro by the Epstein-Barr virus exhibit differential genetical and functional features. Int J Oncol 1997;11:87-96.
20. Stewart JP, Arrand JR. Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimens. Hum Pathol 1993;24:239-42.
21. Sheu LF, Chen A, Wei YH, Ho KC, Cheng JY, Meng CL, et al. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis. Am J Pathol 1998;152:63-74.
22. Contesso G, Bertin F, Mathieu MC, Terrier P. Anatomie pathologique des cancers mammaires. Techniques ed. Encycl Med Chir 1991;865: 1-17.
23. Gotteland M, May E, May-Levin F, Contesso G, Delarue JC, Mouriesse H. Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents. Cancer 1994;74:864-71.
24. Grasser FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W, et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 1994;84:3792-8.
25. Mehta CR, Patel NR. A hybrid algorithm for Fisher's exact test in unordered rxc contingency tables. Comm Statis, Theory and Methods 1986;15: 387-403.
26. Mehta CR, Patel NR, Tsiatis AA. Exact significance testing to establish treatment equivalence with ordered categorical data. Bometrics 1984;40: 819-25.
27. Lestou VS, Strehl S, Lion T, Gadner H, Ambros PF. High-resolution FISH of the entire integrated Epstein-Barr virus genome on extended human DNA. Cytogenet Cell Genet 1996;74:211-7.
28. Grunewald V, Bonnet M, Boutin S, Yip T, Louzir H, Levrero M, et al. Amino-acid change in the Epstein-Barr virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa. Int J Cancer 1998;75:497-503.
29. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 1995;80:593-601.
30. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995;146:1355-67.
31. Takeuchi H, Kobayashi R, Hasegawa M, Hirai K. Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR. Arch Virol 1997;142:1743-56.
32. Wilson JB, Bell JL, Levine AJ. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 1996;15: 3117-26.
33. Tokunaga M, Uemura Y, Tokudome T, Ishidate T, Masuda H, Okazaki E, et al. Epstein-Barr virus related gastric cancer in Japan: a molecular pathoepidemiological study. Acta Pathol Jpn 1993;43:574-81.